FDA Warning Letter — LXR Biotech
The FDA took a Warning Letter action against LXR Biotech on July 17, 2023 (Rochester Hills, MI). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- LXR Biotech
- Date
- July 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Rochester Hills, MI (United States)